- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on NSCLC
Total 1030 results
-
Hospices Civils de LyonRecruitingMetastatic Breast Cancer | Metastatic NSCLC | Metastases to BoneFrance
-
CTI BioPharmaTerminatedNSCLCUnited States, Canada, Bulgaria, Romania, Russian Federation, Ukraine, Mexico, Argentina, Hungary, Poland, United Kingdom
-
Shenzhen Geno-Immune Medical InstituteWithdrawn
-
Dana-Farber Cancer InstituteDamon Runyon Cancer Research FoundationRecruitingMelanoma | NSCLCUnited States
-
PfizerActive, not recruitingOvarian Cancer | NSCLC | Solid Tumors | Urothelial Cancer | Advanced MalignanciesHungary, Spain, United States, Canada, Taiwan, Japan, Serbia, Italy, New Zealand, Australia, Mexico, Russian Federation, United Kingdom, France, Korea, Republic of, Belgium, Poland, Denmark, Israel
-
Revolution Medicines, Inc.RecruitingNon-Small Cell Lung Cancer, NSCLC | KRAS, NRAS, HRAS-mutated NSCLC | KRAS G12C-mutated Solid Tumors, Lung Cancer | Lung Cancer Stage IV, Advanced Solid Tumor, CancerUnited States
-
JS InnoPharm, LLCRecruiting
-
Harrison Clinical ResearchMerck KGaA, Darmstadt, Germany; AstraZenecaCompletedHead and Neck Cancer | Colorectal Cancer | Non Small Cell Lung Cancer (NSCLC)Spain, Belgium
-
CJ Bioscience, Inc.RecruitingMelanoma | NSCLC | Metastatic Cancer | Advanced Solid Tumor | Advanced Cancer | HNSCCKorea, Republic of
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, United States, Spain, France, Italy, Korea, Republic of, Poland
-
Shanghai Pulmonary Hospital, Shanghai, ChinaUnknownCirculating Tumor DNA | Advanced NSCLC | Circulating Tumor Cells
-
Maastricht Radiation OncologyKarolinska Institutet; KU Leuven; Maastricht University Medical Center; Catholic... and other collaboratorsWithdrawnNSCLC Stage IV | Limited Metastatic DiseaseNetherlands
-
OSI PharmaceuticalsCompleted
-
AstraZenecaQuintiles, Inc.CompletedNSCLCBulgaria, France, Italy, Mexico, Peru, Russian Federation, Spain, Turkey, United Kingdom, Sweden, Poland, Ukraine, Chile, Hungary, Israel, Netherlands, Portugal, Romania, Germany, Austria, Belgium, Canada, Australia
-
Centre Henri BecquerelCompleted
-
Maastricht Radiation OncologyUniversity Medical Center Groningen; Maastricht University Medical Center; Amsterdam... and other collaboratorsCompleted
-
Inge Marie SvaneCompletedNSCLC | Lung CancerDenmark
-
Betta Pharmaceuticals Co., Ltd.Not yet recruitingA Phase 1 Study of BPI-371153 in Subjects With Advanced Solid Tumors or Relapsed/Refractory LymphomaLymphoma | HCC | NSCLC | Advanced Solid TumorChina
-
AstraZenecaTerminatedUnresectable Stage III NSCLCUnited States
-
Peking University People's HospitalThe First Affiliated Hospital of Zhengzhou University; Jiangsu Cancer Institute... and other collaboratorsCompletedCarcinoma | Lung Neoplasms | NSCLC | Lung CancerChina
-
Fondazione Policlinico Universitario Agostino Gemelli...Active, not recruiting
-
Boryung Pharmaceutical Co., LtdRecruitingSCLCKorea, Republic of
-
Biotheus Inc.Recruiting
-
Biotheus Inc.Recruiting
-
Shanghai Chest HospitalRecruiting
-
Radiotherapy Oncology Centre "Santa Maria" HospitalPaola Anselmo,MD; Michelina Casale,PhD; Fabio Trippa,MDRecruitingNSCLC | Non Small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | NSCLC Stage IV | Oligometastatic Disease | Non-Small Cell Squamous Lung Cancer | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor | Non-Small Cell Adenocarcinoma and other conditionsItaly
-
Bristol-Myers SquibbRecruitingNSCLCUnited States, Argentina, Chile, France, Italy, Poland, Romania, Spain
-
Mirati Therapeutics Inc.RecruitingMetastatic Lung Cancer | Advanced NSCLCUnited States, Spain, Greece, Hungary, France, Italy, Poland
-
Instituto do Cancer do Estado de São PauloCompleted
-
Alethia BiotherapeuticsCompletedNSCLC Stage IVUnited States, Canada
-
Cancer Trials IrelandUniversity College Dublin; Technological University DublinRecruitingNSCLC/Oligometastatic Cancer (Single Lung Lesion)Ireland
-
Hoffmann-La RocheCompletedNon-Small Cell Lung Cancer (NSCLC)Spain
-
Fundacion Clinic per a la Recerca BiomédicaCompletedNon-Small Cell Lung Cancer (NSCLC)Spain
-
Jiangsu HengRui Medicine Co., Ltd.UnknownNSCLC | Neutropenia | Febrile NeutropeniaChina
-
University Hospital, EssenCompletedNSCLC | EGFR T790M | FDG-PETGermany
-
Zhejiang Cancer HospitalHangzhou Cancer HospitalUnknown
-
European Georges Pompidou HospitalAPHPRecruitingProgression | Surgery | NSCLC, Stage I, II, IIIA, IIIB | Epithelial Mesenchymal TransitionFrance
-
Peking University People's HospitalUnknownCarcinoma | NSCLC | Lung Cancer | Lung NeoplasmChina
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Minimal Residual Disease | NSCLC Stage IV | Nsclc | Metastatic Non Small Cell Lung CancerUnited States
-
Charite University, Berlin, GermanyRecruitingHead and Neck Cancer | Esophageal Cancer | NSCLC | Prostate Cancer | SCLC | Bladder Cancer | Cervix Cancer | Rectum Cancer | Other CarcinomaGermany
-
RayzeBio, Inc.RecruitingSCLC,Extensive StageUnited States
-
Bristol-Myers SquibbCompletedLung Cancer (NSCLC)China, Germany, Singapore, Hungary, Korea, Republic of, Poland
-
Smartfish ASCompletedNSCLC | CachexiaItaly, Sweden, Croatia, Slovakia
-
Li Zhang, MDRecruitingThe Diagnosis Was ALK Positive NSCLC | Second Generation ALK-TKI is Resistant | Efficacy of Ensatinib in This Subset of PatientsChina
-
Samsung Medical CenterNational Evidence-Based Healthcare Collaborating AgencyRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of
-
St. Joseph's Healthcare HamiltonCompletedNSCLC | Lung Cancer | Artificial Intelligence | Elastography | Endobronchial UltrasoundCanada
-
TakedaWithdrawnNon-small Cell Lung Cancer (NSCLC)China
-
Stanford UniversityCompletedNon-small Cell Lung Cancer (NSCLC)United States, Japan, Canada
-
University of LouisvilleJames Graham Brown Cancer CenterWithdrawnNon-small Cell Lung Cancer (NSCLC)United States
-
Ethicon Endo-Surgery (Europe) GmbHCompleted